_version_ 1785091121685200896
author Bátai, Bence
Nagy, Ákos
Kiss, Laura
Gróf, Stefánia
Attila Király, Péter
Jóna, Ádám
Demeter, Judit
Santa, Hermina
Batai, Arpad
Pettendi, Piroska
Szendrei, Tamás
Béla Plander, Márk
Kőrösmezey, Gábor
Alizadeh, Hussain
Kajtár, Béla
Méhes, Gábor
Krenács, László
Timár, Botond
Csomor, Judit
Tóth, Erika
Schneider, Tamás
Mikala, Gabor
Matolcsy, András
Alpar, Donat
Masszi, András
Bödör, Csaba
author_facet Bátai, Bence
Nagy, Ákos
Kiss, Laura
Gróf, Stefánia
Attila Király, Péter
Jóna, Ádám
Demeter, Judit
Santa, Hermina
Batai, Arpad
Pettendi, Piroska
Szendrei, Tamás
Béla Plander, Márk
Kőrösmezey, Gábor
Alizadeh, Hussain
Kajtár, Béla
Méhes, Gábor
Krenács, László
Timár, Botond
Csomor, Judit
Tóth, Erika
Schneider, Tamás
Mikala, Gabor
Matolcsy, András
Alpar, Donat
Masszi, András
Bödör, Csaba
author_sort Bátai, Bence
collection PubMed
description
format Online
Article
Text
id pubmed-10431108
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311082023-08-17 P1245: PARALLEL TESTING OF LIQUID BIOPSY (CTDNA) AND TISSUE BIOPSY SAMPLES REVEALS A HIGHER FREQUENCY OF TARGETABLE EZH2 MUTATIONS IN FOLLICULAR LYMPHOMA Bátai, Bence Nagy, Ákos Kiss, Laura Gróf, Stefánia Attila Király, Péter Jóna, Ádám Demeter, Judit Santa, Hermina Batai, Arpad Pettendi, Piroska Szendrei, Tamás Béla Plander, Márk Kőrösmezey, Gábor Alizadeh, Hussain Kajtár, Béla Méhes, Gábor Krenács, László Timár, Botond Csomor, Judit Tóth, Erika Schneider, Tamás Mikala, Gabor Matolcsy, András Alpar, Donat Masszi, András Bödör, Csaba Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431108/ http://dx.doi.org/10.1097/01.HS9.0000971872.30328.9c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Bátai, Bence
Nagy, Ákos
Kiss, Laura
Gróf, Stefánia
Attila Király, Péter
Jóna, Ádám
Demeter, Judit
Santa, Hermina
Batai, Arpad
Pettendi, Piroska
Szendrei, Tamás
Béla Plander, Márk
Kőrösmezey, Gábor
Alizadeh, Hussain
Kajtár, Béla
Méhes, Gábor
Krenács, László
Timár, Botond
Csomor, Judit
Tóth, Erika
Schneider, Tamás
Mikala, Gabor
Matolcsy, András
Alpar, Donat
Masszi, András
Bödör, Csaba
P1245: PARALLEL TESTING OF LIQUID BIOPSY (CTDNA) AND TISSUE BIOPSY SAMPLES REVEALS A HIGHER FREQUENCY OF TARGETABLE EZH2 MUTATIONS IN FOLLICULAR LYMPHOMA
title P1245: PARALLEL TESTING OF LIQUID BIOPSY (CTDNA) AND TISSUE BIOPSY SAMPLES REVEALS A HIGHER FREQUENCY OF TARGETABLE EZH2 MUTATIONS IN FOLLICULAR LYMPHOMA
title_full P1245: PARALLEL TESTING OF LIQUID BIOPSY (CTDNA) AND TISSUE BIOPSY SAMPLES REVEALS A HIGHER FREQUENCY OF TARGETABLE EZH2 MUTATIONS IN FOLLICULAR LYMPHOMA
title_fullStr P1245: PARALLEL TESTING OF LIQUID BIOPSY (CTDNA) AND TISSUE BIOPSY SAMPLES REVEALS A HIGHER FREQUENCY OF TARGETABLE EZH2 MUTATIONS IN FOLLICULAR LYMPHOMA
title_full_unstemmed P1245: PARALLEL TESTING OF LIQUID BIOPSY (CTDNA) AND TISSUE BIOPSY SAMPLES REVEALS A HIGHER FREQUENCY OF TARGETABLE EZH2 MUTATIONS IN FOLLICULAR LYMPHOMA
title_short P1245: PARALLEL TESTING OF LIQUID BIOPSY (CTDNA) AND TISSUE BIOPSY SAMPLES REVEALS A HIGHER FREQUENCY OF TARGETABLE EZH2 MUTATIONS IN FOLLICULAR LYMPHOMA
title_sort p1245: parallel testing of liquid biopsy (ctdna) and tissue biopsy samples reveals a higher frequency of targetable ezh2 mutations in follicular lymphoma
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431108/
http://dx.doi.org/10.1097/01.HS9.0000971872.30328.9c
work_keys_str_mv AT bataibence p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT nagyakos p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT kisslaura p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT grofstefania p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT attilakiralypeter p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT jonaadam p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT demeterjudit p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT santahermina p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT bataiarpad p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT pettendipiroska p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT szendreitamas p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT belaplandermark p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT korosmezeygabor p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT alizadehhussain p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT kajtarbela p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT mehesgabor p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT krenacslaszlo p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT timarbotond p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT csomorjudit p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT totherika p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT schneidertamas p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT mikalagabor p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT matolcsyandras p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT alpardonat p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT massziandras p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma
AT bodorcsaba p1245paralleltestingofliquidbiopsyctdnaandtissuebiopsysamplesrevealsahigherfrequencyoftargetableezh2mutationsinfollicularlymphoma